Reply to: Burosumab for Tumor-Induced Osteomalacia: not Enough of a Good Thing.

ABSTRACT:

SUBMITTER: Jan de Beur SM 

PROVIDER: S-EPMC9290665 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature